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The segments were tied at one end, ﬁlled with Krebs-Henseleit solution,
and then tied at the other end. Each sac was individually placed in a 20 ml
glass tube containing oxygenated Krebs Henseleit solution with Hyal-Joint®
at a ﬁnal concentration of 200 μg/ml and was incubated at 37°C. The whole
samples of the inside medium were taken at 5, 10, 20 and 30 minutes. The
amount of Hyal-Joint® absorbed was determined following the technique
described by Farndale et al (1982) for glycosaminoglycan determination.
Results: The compound Hyal-Joint® was able to reduce in vitro the PGE2
and MMP-1 levels induced by the inﬂammatory cytokine IL-1β. In the
case of PGE2, Hyal-Joint® inhibited 70, 47 and 49% the PGE2 production
at 500, 50 and 5 μg/ml, respectively, and thus inhibits Cox-2 activity. In
addition this compound inhibits the IL-1β-induced production of MMP-1 at
all concentrations, being more effective at 5 μg/ml than at 500 μg/ml.
The study of absorption showed that the extract was absorbed from the
medium through the intestinal mucous membrane. The absorption was
higher in the duodenum (38%), and subsequently in the jejunum (22%) and
ileum (9%).
Conclusions: The present study indicates that Hyal-Joint® has anti-
inﬂammatory effects and is absorbed well through the intestine. Thus, the
natural compound Hyal-Joint® may be useful as a nutritional supplement
for maintaining joint integrity and function.
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Purpose: Patients undergoing total hip replacement surgery due to pri-
mary or secondary osteoarthritis in their hip occationally need revision
surgery because of a periprosthetic deep tissue infection. In most cases,
these patients undergo a 2-stage procedure, that consists of a temporary
antibiotic containing polymethylmethacrylate (PMMA) spacer insertion and
later implantation of a new permanent hip prosthesis. The aim of our study
was to examine the microscopic structure and the elemental composition
of such an antibiotic containing PMMA hip spacer after removal from the
patient.
Methods: For the investigation we have used a gentamicin containing
PMMA spacer which has spent 45 days in a patinent’s right hip joint after
removal of an infected implant. We have carried out scanning electron
microscopy combined with energy-dispersive X-ray spectroscopic analysis
(SEM/EDS) to image and identify the building blocks of the spacer material.
With X-ray ﬂuorescence analysis we have measured the sulphur content
on surfaces of segments from different depths within our specimen in
order to estimate their gentamicin sulphate concentration. Finally, we have
performed scanning electronmicroscope (SEM) imaging in the same depths
to visualise changes of the gentamicin particles both in deep and superﬁcial
layers of PMMA matrix.
Results: SEM/EDS analysis has revealed the location and shape of PMMA,
gentamicin and barium-sulphate particles in the spacer matrix, and has
detected the presence of calcium, which was not present in the control
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sample. X-ray ﬂuorescence analysis has detected a gradually declining
gentamicin sulphate concentration from the center to the surface of the
specimen. The corresponding SEM ﬁndings have shown many voids visible
at lower magniﬁcation. Gap was visible between gentamicin particles and
PMMA matrix both on samples from superﬁcial and deep-lying parts of the
spacer.
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Conclusions: Voids visible at lower magniﬁcation on SEM micrographs
resulted from conventional manual mixing technique, and may have con-
tributed to gaps between gentamicin particles and PMMA matrix both
on samples from superﬁcial and deep-lying parts of the sample. Lower
concentration of gentamicin sulphate close to the spacer surface means that
diffusion closer to body ﬂuids was more effective in removing gentamicin
from the spacer matrix. Since calcium cannot be detected in the control
sample, we can assume that it has moved into the spacer material by
diffusion from body ﬂuids or bone tissue that surrounded the sample
during the 45 days spent in the human body. More investigation is needed
to reveal the role and extent of calcium migration into the deeper-lying
parts of the implanted bone cement.
